Scott Lilly, MD
Interventional Cardiology · Gahanna, OHNPI 1932263274
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $14,575 of the $18,406 with a category attached, or 79.2%. Edwards Lifesciences accounts for 87.4% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $12,425, more than ten times the $580 reported in 2019.
Across 43 payments — averaging $428.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$16K
- Abbott$2K
- Boston Scientific$547
- Medtronic$70
- Abiomed$51
- Procyrion, Inc.$41
- plus $25 from 1 others
Across 195 payments — averaging $4646.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$456K
- Abbott$172K
- Medtronic$149K
- Baxter Healthcare$70K
- Shockwave Medical, Inc$39K
- Boston Scientific$20K
What the payments were for
- Consulting fees$14,57579%
- Travel & lodging$2,58914%
- Food & beverage$1,2427%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 18 | $16,089 |
| Abbott | 14 | $1,582 |
| Boston Scientific | 6 | $547 |
| Medtronic | 1 | $70 |
| Abiomed | 2 | $51 |
| Procyrion, Inc. | 1 | $41 |
| Livanova USA, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRICLIP$1,118
- GENERAL - THERAPIES$172
- AVVIGO Guidance System$147
- Mitra Clip system$110
How this compares
$18,406 in reported general payments places this provider in the 75th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 21 | $21,855 |
| Metoprolol Succinate | 80 | $1,503 |
| Atorvastatin Calcium | 92 | $582 |
| Carvedilol | 47 | $397 |
| Rosuvastatin Calcium | 26 | $298 |
| ClopidogrelClopidogrel Bisulfate | 26 | $294 |
| Amlodipine Besylate | 64 | $284 |
| Metoprolol Tartrate | 36 | $256 |
| Furosemide | 32 | $207 |
| Pravastatin Sodium | 11 | $174 |
| Losartan Potassium | 17 | $127 |
| Lisinopril | 38 | $124 |
| Warfarin Sodium | 12 | $118 |
| Hydrochlorothiazide | 27 | $22 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Gahanna
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Carlos Sanchez SotoColumbus$1.1M
- Steven YakubovColumbus$907K
- Timothy HenryCincinnati$605K
- Mitchell SilverColumbus$562K
- John PhillipsColumbus$410K
- John CorlCincinnati$390K
- Santiago GarciaCincinnati$360K
- Atish MathurMansfield$291K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.